+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Vaccine Market - Global Forecast 2026-2032- Product Image
Allergy Vaccine Market - Global Forecast 2026-2032- Product Image
New

Allergy Vaccine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905049
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Dynamic shifts across the allergy vaccine market are shaping how clinical, commercial, and operational leaders approach differentiation, compliance, and long-term patient engagement. To maintain a competitive edge, senior decision-makers now face the challenge of adapting rapidly to evolving distribution models and regulatory expectations in this specialized biopharmaceutical sector.

Market Snapshot: Allergy Vaccine Market Size and Growth

The allergy vaccine market recorded growth from USD 1.60 billion in 2025 to USD 1.79 billion in 2026, and is projected to reach USD 3.90 billion by 2032, supported by a robust CAGR of 13.58%. Intensive development within recombinant vaccine technologies, along with digital distribution advancements and increased attention to patient-centric care delivery, is driving sustained expansion. Regulatory policy changes and demands for improved patient management contribute to a complex context, affecting both commercial and operational decision-making as organizations seek alignment with market realities.

Scope & Segmentation Across the Allergy Vaccine Value Chain

  • Administration Routes: Both subcutaneous immunotherapy (standard and accelerated dosing) and sublingual immunotherapy (using drops or tablets) influence patient adherence and integrate differently with clinical workflows.
  • Allergen Targets: The market serves perennial allergens (like dust mite and animal dander) as well as seasonal allergens (such as pollen and molds), necessitating unique antigen selection and portfolio strategies.
  • Vaccine Formats: Monovalent and polyvalent vaccines are available, each shaping patient selection, regulatory submission approaches, and product positioning.
  • Technology Platforms: Recombinant antigen-based and extract-based vaccines form the technology backbone, offering varying degrees of scalability, production standardization, and safety benefits in clinical practice.
  • Distribution Channels: Hospital pharmacies, online dispensaries, and retail pharmacies all represent key delivery points, with a distinct shift toward home delivery and digital dispensing shaping market access.
  • End-User Groups: The patient base encompasses adults, pediatrics, and geriatric populations, each requiring tailored dosing regimens, safety protocols, and communication strategies for optimal outcomes.
  • Care Settings: Clinics, hospitals, and home healthcare facilities are integral to administration logistics, each introducing specific challenges for reimbursement policies and patient oversight.
  • Regions Covered: The report analyzes the Americas, Europe, Middle East & Africa, and Asia-Pacific, where diverse regulatory landscapes and demographic shifts create regional opportunities and risks for manufacturers and distributors.

Understanding these segments allows stakeholders to uncover avenues for innovation, navigate evolving compliance obligations, and target new partnerships. Segment-level clarity supports more adaptable commercial models and sharper differentiation in highly regulated environments.

Key Takeaways for Senior Decision-Makers

  • The expansion of recombinant vaccine technologies has elevated industry standards, setting new benchmarks for quality, consistency, and regulatory acceptance across major regional markets.
  • Accelerated subcutaneous dosing and advances in sublingual delivery improve patient adherence and streamline practitioner workflows, contributing to greater operational throughput and resource efficiency.
  • Growth in digital health and alternative dispensing channels is reshaping patient access strategies, fostering improved adherence outside of traditional clinical environments and diversifying market entry points.
  • Commercialization and product planning must now incorporate robust real-world evidence and economic validation, as expectations from payers and regulators influence go-to-market timelines and reimbursement policies.
  • Manufacturers are adapting to heightened operational pressures by focusing on cost-containment, scalable production, and risk-managed sourcing to remain resilient in volatile supply and tariff environments.
  • Consolidation and partnerships are accelerating, especially among smaller market participants facing rising production costs and the need for supply chain flexibility.

Tariff Impact on Sourcing, Manufacturing, and Pricing

Anticipated tariff changes in the United States for 2025 are escalating the importance of agile, cost-effective sourcing and diversified supply chains within the allergy vaccine market. Organizations with integrated or multi-location production structures can better cushion supply chain disruptions, while those relying on single suppliers may need to revisit pricing tactics or negotiate new supply agreements. These shifts are fostering greater industry consolidation and alliances, as well as dialogue with policymakers to safeguard equitable pricing and ensure uninterrupted patient access.

Methodology & Data Sources

This report’s foundation rests on direct expert interviews with clinical investigators, regulatory consultants, supply chain professionals, and commercial executives. Peer-reviewed research, clinical trial databases, and the latest regulatory filings complement this primary intelligence. Rigorous multi-source analysis and granular segmentation assure an impartial and actionable research approach.

Why This Report Matters

  • Empowers leaders to build integrated programs connecting clinical development with operational efficiency across multiple care settings and global regions.
  • Supports proactive adaptation to regulatory and payer shifts, enhancing readiness for pricing changes and fostering robust industry partnerships.
  • Facilitates identification of risks, directs investment decisions, and guides tactical planning for long-term supply chain continuity and market resilience.

Conclusion

Success in the allergy vaccine market depends on integrating innovation, robust sourcing, and agile commercial execution. This report provides a practical framework for strategic planning and risk management within a dynamic and evolving market landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Allergy Vaccine Market, by Vaccine Type
8.1. Monovalent
8.2. Polyvalent
9. Allergy Vaccine Market, by Route Of Administration
9.1. Subcutaneous Immunotherapy
9.1.1. Accelerated Doses
9.1.2. Standard Doses
9.2. Sublingual Immunotherapy
9.2.1. Drops
9.2.2. Tablets
10. Allergy Vaccine Market, by Allergens Targeted
10.1. Perennial Allergens
10.1.1. Animal Dander
10.1.2. Dust Mite
10.2. Seasonal Allergens
10.2.1. Molds
10.2.2. Pollen
11. Allergy Vaccine Market, by Technology
11.1. Recombinant
11.2. Traditional Extract
12. Allergy Vaccine Market, by Patient Age Group
12.1. Adult
12.2. Geriatric
12.3. Pediatric
13. Allergy Vaccine Market, by End User
13.1. Clinics
13.2. Home Healthcare
13.3. Hospitals
14. Allergy Vaccine Market, by Distribution Channel
14.1. Hospital Pharmacies
14.2. Online Pharmacies
14.3. Retail Pharmacies
15. Allergy Vaccine Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Allergy Vaccine Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Allergy Vaccine Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Allergy Vaccine Market
19. China Allergy Vaccine Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Adamis Pharmaceuticals Corporation
20.6. ALK-Abelló A/S
20.7. Allergopharma GmbH & Co. KG
20.8. Allergy Therapeutics plc
20.9. Anergis SA
20.10. Biomay AG
20.11. Boehringer Ingelheim International GmbH
20.12. Circassia Group plc
20.13. CSL Limited
20.14. DBV Technologies S.A.
20.15. HAL Allergy B.V.
20.16. Inmunotek S.L.
20.17. Jubilant HollisterStier LLC
20.18. Laboratorios LETI, S.L.U.
20.19. Merck KGaA
20.20. Mitsubishi Tanabe Pharma Corporation
20.21. Novartis International AG
20.22. Pfizer Inc.
20.23. Regeneron Pharmaceuticals, Inc.
20.24. Sanofi S.A.
20.25. Stallergenes Greer International AG
20.26. Thermo Fisher Scientific Inc.
20.27. Torii Pharmaceutical Co., Ltd.
20.28. Zhejian Wolwo Bio-pharmaceutical Co., Ltd.
20.29. Zydus Lifesciences Ltd.
List of Figures
FIGURE 1. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES ALLERGY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA ALLERGY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MONOVALENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MONOVALENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLYVALENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLYVALENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLYVALENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ACCELERATED DOSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ACCELERATED DOSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ACCELERATED DOSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY STANDARD DOSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY STANDARD DOSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY STANDARD DOSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ANIMAL DANDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ANIMAL DANDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DUST MITE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DUST MITE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DUST MITE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MOLDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MOLDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ALLERGY VACCINE MARKET SIZE, BY MOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLLEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLLEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ALLERGY VACCINE MARKET SIZE, BY POLLEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TRADITIONAL EXTRACT, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TRADITIONAL EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TRADITIONAL EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPE ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 143. EUROPE ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 147. EUROPE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 163. AFRICA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164. AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 165. AFRICA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 166. AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 167. AFRICA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 168. AFRICA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 169. AFRICA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. AFRICA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 171. AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. AFRICA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 189. ASEAN ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 191. ASEAN ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 192. ASEAN ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 193. ASEAN ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 194. ASEAN ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. ASEAN ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 196. ASEAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. ASEAN ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. GCC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GCC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 200. GCC ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201. GCC ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 202. GCC ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 203. GCC ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 204. GCC ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 205. GCC ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 206. GCC ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. GCC ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 208. GCC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. GCC ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. BRICS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. BRICS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRICS ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. BRICS ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 226. BRICS ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 227. BRICS ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 228. BRICS ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 229. BRICS ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 230. BRICS ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. BRICS ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 232. BRICS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. BRICS ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. G7 ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. G7 ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 236. G7 ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237. G7 ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 238. G7 ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 239. G7 ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 240. G7 ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 241. G7 ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 242. G7 ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 243. G7 ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 244. G7 ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. G7 ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. NATO ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. NATO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 248. NATO ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. NATO ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 250. NATO ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 251. NATO ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 252. NATO ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 253. NATO ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 254. NATO ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 255. NATO ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 256. NATO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. NATO ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES ALLERGY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 271. CHINA ALLERGY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. CHINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 273. CHINA ALLERGY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. CHINA ALLERGY VACCINE MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 275. CHINA ALLERGY VACCINE MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 276. CHINA ALLERGY VACCINE MARKET SIZE, BY ALLERGENS TARGETED, 2018-2032 (USD MILLION)
TABLE 277. CHINA ALLERGY VACCINE MARKET SIZE, BY PERENNIAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 278. CHINA ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGENS, 2018-2032 (USD MILLION)
TABLE 279. CHINA ALLERGY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 280. CHINA ALLERGY VACCINE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 281. CHINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. CHINA ALLERGY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Allergy Vaccine market report include:
  • Adamis Pharmaceuticals Corporation
  • ALK-Abelló A/S
  • Allergopharma GmbH & Co. KG
  • Allergy Therapeutics plc
  • Anergis SA
  • Biomay AG
  • Boehringer Ingelheim International GmbH
  • Circassia Group plc
  • CSL Limited
  • DBV Technologies S.A.
  • HAL Allergy B.V.
  • Inmunotek S.L.
  • Jubilant HollisterStier LLC
  • Laboratorios LETI, S.L.U.
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis International AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Stallergenes Greer International AG
  • Thermo Fisher Scientific Inc.
  • Torii Pharmaceutical Co., Ltd.
  • Zhejian Wolwo Bio-pharmaceutical Co., Ltd.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.79 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.9 Billion
Compound Annual Growth Rate13.5%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Allergy Vaccines Market - Global Strategic Business Report - Product Image

Allergy Vaccines Market - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Allergy Immunotherapy Market - Global Forecast 2026-2032 - Product Image

Allergy Immunotherapy Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Peanut Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Peanut Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Allergy Immunotherapy Market Report 2025 - Product Image

Allergy Immunotherapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Allergy Vaccine Market

The Allergy Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Allergy Vaccines are specifically designed to reduce the severity of allergic reactions, such as hay fever, asthma, and food allergies. These vaccines are typically administered through a series of injections, which can be tailored to the individual patient's needs. Allergy Vaccines are becoming increasingly popular as a way to reduce the burden of allergic reactions, and are being used in both adults and children. They are also being used in combination with other treatments, such as antihistamines and immunotherapy, to provide a more comprehensive approach to managing allergies. Some companies in the Allergy Vaccine market include ALK-Abello, Stallergenes Greer, Allergy Therapeutics, and DBV Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.